Polyester microparticles as a vaccine delivery system for brucellosis:: Influence of the polymer on release, phagocytosis and toxicity

被引:20
作者
Murillo, M
Gamazo, C
Irache, JM
Goñi, MM
机构
[1] Univ Navarra, Dept Farm & Tecnol Farmaceut, Navarra 31080, Spain
[2] Univ Navarra, Dept Microbiol, Navarra 31080, Spain
关键词
brucellosis; microparticles; phagocytosis; PLGA; poly-epsilon-caprolactone; vaccine;
D O I
10.1080/10611860290022642
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microparticles, containing an antigenic complex from Brucella ovis (HS), were evaluated for vaccine purposes against brucellosis. They were prepared by the double emulsion solvent evaporation method using two different polyesters, poly-lactide-co-glycolide acid (75:25; RG 756) and poly-epsilon-caprolactone. The encapsulation efficiency and release of HS from the microparticles, their capacity to be phagocytosed and also their toxicity on murine monocytes J774.2 were investigated. Both polymers lead to smooth and spherical sub-5 mum particles, with approximately 30% of the antigen initial dose encapsulated. SDS-PAGE and immunoblot of extracted antigens confirmed that the apparent molecular weight and antigenicity remained unaltered after the encapsulation procedure. However, the in vitro release of the antigens differed among them. The release profile for PLGA microparticles was continuous, whereas PEC ones released the antigens in a triphasic release pattern. Phagocytosis was clearly influenced by the hydrophobicity of the polymer, increasing in the case of PEC microparticles. Toxicity assay showed that both types of microparticles induced similar levels of mitochondrial damage. In conclusion, HS-PEC microparticles could be used as an effective vaccine against brucellosis, as the antigen is released in boosters and they are greatly phagocytosed by macrophages.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 38 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]   Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen [J].
Baras, B ;
Benoit, MA ;
Dupré, L ;
Poulain-Godefroy, O ;
Schacht, AM ;
Capron, A ;
Gillard, J ;
Riveau, G .
INFECTION AND IMMUNITY, 1999, 67 (05) :2643-2648
[3]   BRUCELLA-MELITENSIS REV-1 VACCINE AS A CAUSE OF HUMAN BRUCELLOSIS [J].
BLASCO, JM ;
DIAZ, R .
LANCET, 1993, 342 (8874) :805-805
[4]   EVALUATION OF WHOLE-CELL AND SUBCELLULAR VACCINES AGAINST BRUCELLA-OVIS IN RAMS [J].
BLASCO, JM ;
GAMAZO, C ;
WINTER, AJ ;
DEBAGUES, MPJ ;
MARIN, C ;
BARBERAN, M ;
MORIYON, J ;
ALONSOURMENETA, B ;
DIAZ, R .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 37 (3-4) :257-270
[5]  
BLASCO JM, 1990, ANIMAL BRUCELLOSIS, P9
[6]  
BUMETTE WN, 1981, ANAL BIOCHEM, V112, P195
[7]   Single-administration vaccines: controlled-release technology to mimic repeated immunizations [J].
Cleland, JL .
TRENDS IN BIOTECHNOLOGY, 1999, 17 (01) :25-29
[8]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[9]  
DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P632
[10]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214